Latest research report on “Urokinase Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5560618
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
This report contains market size and forecasts of Urokinase in global, including the following market information:
Global Urokinase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Urokinase Market Sales, 2017-2022, 2023-2028, (BIU)
Global top five Urokinase companies in 2021 (%)
The global Urokinase market was valued at 46 million in 2021 and is projected to reach US$ 65 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Urokinase Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Urokinase include Syner-Med, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems and LIVZON, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Urokinase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urokinase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (BIU)
Global Urokinase Market Segment Percentages, by Type, 2021 (%)
– Urokinase Powder
– Urokinase Solution
Global Urokinase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (BIU)
Global Urokinase Market Segment Percentages, by Application, 2021 (%)
Global Urokinase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (BIU)
Global Urokinase Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Urokinase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Urokinase revenues share in global market, 2021 (%)
Key companies Urokinase sales in global market, 2017-2022 (Estimated), (BIU)
Key companies Urokinase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Wanhua Biochem
– Jiangxi Haoran Bio-Pharma
– Jiangsu Aidea Pharmaceutical
– Microbic Biosystems
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5560618
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441